nodes	percent_of_prediction	percent_of_DWPC	metapath
Gefitinib—ALB—systemic lupus erythematosus	0.136	1	CbGaD
Gefitinib—ABCG2—Leflunomide—systemic lupus erythematosus	0.046	0.0935	CbGbCtD
Gefitinib—ABCG2—Mycophenolate mofetil—systemic lupus erythematosus	0.0284	0.0577	CbGbCtD
Gefitinib—ABCG2—Hydrocortisone—systemic lupus erythematosus	0.0228	0.0463	CbGbCtD
Gefitinib—ABCG2—Cyclosporine—systemic lupus erythematosus	0.0215	0.0438	CbGbCtD
Gefitinib—ALB—Mycophenolate mofetil—systemic lupus erythematosus	0.0196	0.0398	CbGbCtD
Gefitinib—CYP3A5—Dapsone—systemic lupus erythematosus	0.0181	0.0369	CbGbCtD
Gefitinib—STK10—renal vein—systemic lupus erythematosus	0.0171	0.191	CbGeAlD
Gefitinib—CYP2C9—Leflunomide—systemic lupus erythematosus	0.0171	0.0347	CbGbCtD
Gefitinib—CYP3A5—Mycophenolate mofetil—systemic lupus erythematosus	0.0157	0.032	CbGbCtD
Gefitinib—ALB—Prednisone—systemic lupus erythematosus	0.0157	0.0318	CbGbCtD
Gefitinib—CYP2C19—Dapsone—systemic lupus erythematosus	0.0146	0.0298	CbGbCtD
Gefitinib—ABCG2—Dexamethasone—systemic lupus erythematosus	0.0142	0.0288	CbGbCtD
Gefitinib—ABCB1—Methylprednisolone—systemic lupus erythematosus	0.0135	0.0275	CbGbCtD
Gefitinib—CYP1A1—Dexamethasone—systemic lupus erythematosus	0.0131	0.0266	CbGbCtD
Gefitinib—CYP3A5—Hydrocortisone—systemic lupus erythematosus	0.0126	0.0257	CbGbCtD
Gefitinib—CYP2C9—Dapsone—systemic lupus erythematosus	0.0122	0.0247	CbGbCtD
Gefitinib—CYP3A5—Cyclosporine—systemic lupus erythematosus	0.0119	0.0242	CbGbCtD
Gefitinib—ABCG2—Methotrexate—systemic lupus erythematosus	0.0114	0.0232	CbGbCtD
Gefitinib—ABCB1—Mycophenolate mofetil—systemic lupus erythematosus	0.0102	0.0208	CbGbCtD
Gefitinib—CYP2C19—Prednisone—systemic lupus erythematosus	0.0101	0.0206	CbGbCtD
Gefitinib—CYP2C19—Cyclosporine—systemic lupus erythematosus	0.00962	0.0196	CbGbCtD
Gefitinib—ABCB1—Betamethasone—systemic lupus erythematosus	0.00879	0.0179	CbGbCtD
Gefitinib—ABCB1—Prednisolone—systemic lupus erythematosus	0.00867	0.0176	CbGbCtD
Gefitinib—ABCB1—Hydrocortisone—systemic lupus erythematosus	0.00822	0.0167	CbGbCtD
Gefitinib—ABCB1—Prednisone—systemic lupus erythematosus	0.00819	0.0166	CbGbCtD
Gefitinib—CYP3A4—Methylprednisolone—systemic lupus erythematosus	0.0081	0.0165	CbGbCtD
Gefitinib—CYP2C9—Cyclosporine—systemic lupus erythematosus	0.008	0.0163	CbGbCtD
Gefitinib—CYP3A5—Dexamethasone—systemic lupus erythematosus	0.00785	0.016	CbGbCtD
Gefitinib—ALB—Methotrexate—systemic lupus erythematosus	0.00785	0.016	CbGbCtD
Gefitinib—ABCB1—Cyclosporine—systemic lupus erythematosus	0.00776	0.0158	CbGbCtD
Gefitinib—CYP2D6—Cyclosporine—systemic lupus erythematosus	0.00731	0.0149	CbGbCtD
Gefitinib—CYP3A4—Dapsone—systemic lupus erythematosus	0.00708	0.0144	CbGbCtD
Gefitinib—CYP2C19—Dexamethasone—systemic lupus erythematosus	0.00633	0.0129	CbGbCtD
Gefitinib—CYP3A4—Mycophenolate mofetil—systemic lupus erythematosus	0.00614	0.0125	CbGbCtD
Gefitinib—CYP3A4—Triamcinolone—systemic lupus erythematosus	0.00614	0.0125	CbGbCtD
Gefitinib—CYP2C9—cardial valve—systemic lupus erythematosus	0.00595	0.0663	CbGeAlD
Gefitinib—CYP2C9—Dexamethasone—systemic lupus erythematosus	0.00527	0.0107	CbGbCtD
Gefitinib—CYP3A4—Betamethasone—systemic lupus erythematosus	0.00526	0.0107	CbGbCtD
Gefitinib—CYP3A4—Prednisolone—systemic lupus erythematosus	0.00519	0.0106	CbGbCtD
Gefitinib—ABCB1—Dexamethasone—systemic lupus erythematosus	0.00511	0.0104	CbGbCtD
Gefitinib—CYP3A4—Hydrocortisone—systemic lupus erythematosus	0.00492	0.01	CbGbCtD
Gefitinib—CYP3A4—Prednisone—systemic lupus erythematosus	0.00491	0.00997	CbGbCtD
Gefitinib—CYP2D6—Dexamethasone—systemic lupus erythematosus	0.00482	0.00979	CbGbCtD
Gefitinib—CYP3A4—Cyclosporine—systemic lupus erythematosus	0.00465	0.00945	CbGbCtD
Gefitinib—ABCB1—Methotrexate—systemic lupus erythematosus	0.00411	0.00835	CbGbCtD
Gefitinib—CYP3A4—Dexamethasone—systemic lupus erythematosus	0.00306	0.00623	CbGbCtD
Gefitinib—STK10—blood plasma—systemic lupus erythematosus	0.00169	0.0188	CbGeAlD
Gefitinib—CYP2C19—urine—systemic lupus erythematosus	0.00166	0.0184	CbGeAlD
Gefitinib—SBK1—tendon—systemic lupus erythematosus	0.0015	0.0167	CbGeAlD
Gefitinib—Erlotinib—LTK—systemic lupus erythematosus	0.00139	0.172	CrCbGaD
Gefitinib—CHEK2—tendon—systemic lupus erythematosus	0.00131	0.0145	CbGeAlD
Gefitinib—CYP2C9—urine—systemic lupus erythematosus	0.00128	0.0143	CbGeAlD
Gefitinib—CHEK2—bone marrow—systemic lupus erythematosus	0.00126	0.0141	CbGeAlD
Gefitinib—Afatinib—BLK—systemic lupus erythematosus	0.00119	0.148	CrCbGaD
Gefitinib—ERBB3—connective tissue—systemic lupus erythematosus	0.00116	0.0129	CbGeAlD
Gefitinib—CHEK2—lung—systemic lupus erythematosus	0.00115	0.0128	CbGeAlD
Gefitinib—Bosutinib—CSK—systemic lupus erythematosus	0.00113	0.14	CrCbGaD
Gefitinib—ERBB3—nephron tubule—systemic lupus erythematosus	0.00113	0.0125	CbGeAlD
Gefitinib—MKNK2—connective tissue—systemic lupus erythematosus	0.0011	0.0123	CbGeAlD
Gefitinib—CSNK1E—skin of body—systemic lupus erythematosus	0.00109	0.0121	CbGeAlD
Gefitinib—MKNK2—nephron tubule—systemic lupus erythematosus	0.00107	0.0119	CbGeAlD
Gefitinib—IRAK1—nephron tubule—systemic lupus erythematosus	0.00107	0.0119	CbGeAlD
Gefitinib—ERBB3—skin of body—systemic lupus erythematosus	0.00105	0.0117	CbGeAlD
Gefitinib—CSNK1E—cortex of kidney—systemic lupus erythematosus	0.000998	0.0111	CbGeAlD
Gefitinib—ERBB3—kidney—systemic lupus erythematosus	0.000989	0.011	CbGeAlD
Gefitinib—CYP3A4—urine—systemic lupus erythematosus	0.000978	0.0109	CbGeAlD
Gefitinib—CYP2D6—urine—systemic lupus erythematosus	0.000963	0.0107	CbGeAlD
Gefitinib—Vandetanib—LYN—systemic lupus erythematosus	0.000962	0.12	CrCbGaD
Gefitinib—EPHA6—nervous system—systemic lupus erythematosus	0.000952	0.0106	CbGeAlD
Gefitinib—MAP3K19—lung—systemic lupus erythematosus	0.000934	0.0104	CbGeAlD
Gefitinib—EPHA6—central nervous system—systemic lupus erythematosus	0.000916	0.0102	CbGeAlD
Gefitinib—MKNK2—cortex of kidney—systemic lupus erythematosus	0.000916	0.0102	CbGeAlD
Gefitinib—IRAK1—cortex of kidney—systemic lupus erythematosus	0.000916	0.0102	CbGeAlD
Gefitinib—Vandetanib—LTK—systemic lupus erythematosus	0.000912	0.114	CrCbGaD
Gefitinib—MKNK1—cortex of kidney—systemic lupus erythematosus	0.000904	0.0101	CbGeAlD
Gefitinib—Bosutinib—LYN—systemic lupus erythematosus	0.0009	0.112	CrCbGaD
Gefitinib—IRAK4—lymphoid tissue—systemic lupus erythematosus	0.000867	0.00965	CbGeAlD
Gefitinib—MAP3K19—nervous system—systemic lupus erythematosus	0.000865	0.00963	CbGeAlD
Gefitinib—CYP2C19—blood plasma—systemic lupus erythematosus	0.000864	0.00962	CbGeAlD
Gefitinib—ERBB3—lymphoid tissue—systemic lupus erythematosus	0.00085	0.00946	CbGeAlD
Gefitinib—MAP3K19—central nervous system—systemic lupus erythematosus	0.000833	0.00927	CbGeAlD
Gefitinib—CSNK1E—tendon—systemic lupus erythematosus	0.000828	0.00922	CbGeAlD
Gefitinib—IRAK4—tendon—systemic lupus erythematosus	0.000815	0.00907	CbGeAlD
Gefitinib—MKNK2—lymphoid tissue—systemic lupus erythematosus	0.000808	0.009	CbGeAlD
Gefitinib—MKNK1—lymphoid tissue—systemic lupus erythematosus	0.000798	0.00888	CbGeAlD
Gefitinib—IRAK4—bone marrow—systemic lupus erythematosus	0.000789	0.00879	CbGeAlD
Gefitinib—STK10—kidney—systemic lupus erythematosus	0.000765	0.00852	CbGeAlD
Gefitinib—MKNK2—tendon—systemic lupus erythematosus	0.000759	0.00846	CbGeAlD
Gefitinib—IRAK1—tendon—systemic lupus erythematosus	0.000759	0.00846	CbGeAlD
Gefitinib—EGFR—lung—systemic lupus erythematosus	0.000755	0.00841	CbGeAlD
Gefitinib—MKNK2—bone marrow—systemic lupus erythematosus	0.000736	0.00819	CbGeAlD
Gefitinib—IRAK1—bone marrow—systemic lupus erythematosus	0.000736	0.00819	CbGeAlD
Gefitinib—CSNK1E—lung—systemic lupus erythematosus	0.000726	0.00809	CbGeAlD
Gefitinib—MKNK1—bone marrow—systemic lupus erythematosus	0.000726	0.00809	CbGeAlD
Gefitinib—IRAK4—lung—systemic lupus erythematosus	0.000715	0.00796	CbGeAlD
Gefitinib—ERBB3—lung—systemic lupus erythematosus	0.000701	0.0078	CbGeAlD
Gefitinib—CYP3A5—blood plasma—systemic lupus erythematosus	0.00068	0.00758	CbGeAlD
Gefitinib—CSNK1E—nervous system—systemic lupus erythematosus	0.000673	0.00749	CbGeAlD
Gefitinib—CYP2C9—blood plasma—systemic lupus erythematosus	0.00067	0.00746	CbGeAlD
Gefitinib—MKNK2—lung—systemic lupus erythematosus	0.000666	0.00742	CbGeAlD
Gefitinib—IRAK1—lung—systemic lupus erythematosus	0.000666	0.00742	CbGeAlD
Gefitinib—MAP2K5—cortex of kidney—systemic lupus erythematosus	0.000665	0.00741	CbGeAlD
Gefitinib—IRAK4—nervous system—systemic lupus erythematosus	0.000662	0.00737	CbGeAlD
Gefitinib—MKNK1—lung—systemic lupus erythematosus	0.000658	0.00733	CbGeAlD
Gefitinib—STK10—lymphoid tissue—systemic lupus erythematosus	0.000657	0.00731	CbGeAlD
Gefitinib—ERBB3—nervous system—systemic lupus erythematosus	0.000649	0.00723	CbGeAlD
Gefitinib—CSNK1E—central nervous system—systemic lupus erythematosus	0.000648	0.00721	CbGeAlD
Gefitinib—IRAK4—central nervous system—systemic lupus erythematosus	0.000637	0.0071	CbGeAlD
Gefitinib—ERBB3—central nervous system—systemic lupus erythematosus	0.000625	0.00696	CbGeAlD
Gefitinib—STK10—tendon—systemic lupus erythematosus	0.000617	0.00688	CbGeAlD
Gefitinib—MKNK2—nervous system—systemic lupus erythematosus	0.000617	0.00687	CbGeAlD
Gefitinib—MKNK1—nervous system—systemic lupus erythematosus	0.000609	0.00679	CbGeAlD
Gefitinib—STK10—bone marrow—systemic lupus erythematosus	0.000598	0.00666	CbGeAlD
Gefitinib—MKNK2—central nervous system—systemic lupus erythematosus	0.000594	0.00662	CbGeAlD
Gefitinib—MKNK1—central nervous system—systemic lupus erythematosus	0.000587	0.00653	CbGeAlD
Gefitinib—Vandetanib—BLK—systemic lupus erythematosus	0.000553	0.0688	CrCbGaD
Gefitinib—MAP2K5—tendon—systemic lupus erythematosus	0.000551	0.00614	CbGeAlD
Gefitinib—STK10—lung—systemic lupus erythematosus	0.000542	0.00603	CbGeAlD
Gefitinib—Bosutinib—BLK—systemic lupus erythematosus	0.000517	0.0643	CrCbGaD
Gefitinib—CYP3A4—blood plasma—systemic lupus erythematosus	0.000511	0.00569	CbGeAlD
Gefitinib—CYP2D6—blood plasma—systemic lupus erythematosus	0.000503	0.0056	CbGeAlD
Gefitinib—STK10—nervous system—systemic lupus erythematosus	0.000502	0.00559	CbGeAlD
Gefitinib—MAP2K5—lung—systemic lupus erythematosus	0.000484	0.00539	CbGeAlD
Gefitinib—STK10—central nervous system—systemic lupus erythematosus	0.000483	0.00538	CbGeAlD
Gefitinib—MAP2K5—nervous system—systemic lupus erythematosus	0.000448	0.00499	CbGeAlD
Gefitinib—ORM1—bone marrow—systemic lupus erythematosus	0.000434	0.00483	CbGeAlD
Gefitinib—MAP2K5—central nervous system—systemic lupus erythematosus	0.000431	0.0048	CbGeAlD
Gefitinib—ORM1—lung—systemic lupus erythematosus	0.000393	0.00438	CbGeAlD
Gefitinib—ABCG2—nephron tubule—systemic lupus erythematosus	0.000378	0.00421	CbGeAlD
Gefitinib—ORM1—nervous system—systemic lupus erythematosus	0.000364	0.00405	CbGeAlD
Gefitinib—ABCB1—blood plasma—systemic lupus erythematosus	0.000361	0.00403	CbGeAlD
Gefitinib—CYP3A5—nephron tubule—systemic lupus erythematosus	0.000351	0.00391	CbGeAlD
Gefitinib—ORM1—central nervous system—systemic lupus erythematosus	0.00035	0.0039	CbGeAlD
Gefitinib—CYP1A1—skin of body—systemic lupus erythematosus	0.000335	0.00373	CbGeAlD
Gefitinib—CYP1A1—kidney—systemic lupus erythematosus	0.000315	0.00351	CbGeAlD
Gefitinib—CSNK1E—Danazol—Hydrocortisone—systemic lupus erythematosus	0.000309	0.0889	CbGdCrCtD
Gefitinib—CYP3A5—kidney—systemic lupus erythematosus	0.000308	0.00343	CbGeAlD
Gefitinib—CYP3A5—cortex of kidney—systemic lupus erythematosus	0.0003	0.00334	CbGeAlD
Gefitinib—Vandetanib—VEGFA—systemic lupus erythematosus	0.000294	0.0366	CrCbGaD
Gefitinib—CSNK1E—Danazol—Prednisone—systemic lupus erythematosus	0.000266	0.0765	CbGdCrCtD
Gefitinib—ABCG2—bone marrow—systemic lupus erythematosus	0.00026	0.00289	CbGeAlD
Gefitinib—ABCG2—lung—systemic lupus erythematosus	0.000235	0.00262	CbGeAlD
Gefitinib—CYP3A4—kidney—systemic lupus erythematosus	0.000231	0.00258	CbGeAlD
Gefitinib—CYP2D6—kidney—systemic lupus erythematosus	0.000228	0.00254	CbGeAlD
Gefitinib—CYP1A1—lung—systemic lupus erythematosus	0.000223	0.00249	CbGeAlD
Gefitinib—CYP3A5—lung—systemic lupus erythematosus	0.000219	0.00243	CbGeAlD
Gefitinib—CYP1A1—nervous system—systemic lupus erythematosus	0.000207	0.0023	CbGeAlD
Gefitinib—CYP1A1—central nervous system—systemic lupus erythematosus	0.000199	0.00222	CbGeAlD
Gefitinib—CSNK1E—Dexamethasone—Hydrocortisone—systemic lupus erythematosus	0.000197	0.0567	CbGdCrCtD
Gefitinib—CSNK1E—Betamethasone—Hydrocortisone—systemic lupus erythematosus	0.000197	0.0567	CbGdCrCtD
Gefitinib—CHEK2—Testosterone Propionate—Hydrocortisone—systemic lupus erythematosus	0.00019	0.0547	CbGdCrCtD
Gefitinib—ABCB1—nephron tubule—systemic lupus erythematosus	0.000186	0.00208	CbGeAlD
Gefitinib—CSNK1E—Betamethasone—Methylprednisolone—systemic lupus erythematosus	0.000186	0.0535	CbGdCrCtD
Gefitinib—CSNK1E—Dexamethasone—Methylprednisolone—systemic lupus erythematosus	0.000186	0.0535	CbGdCrCtD
Gefitinib—CSNK1E—Dexamethasone—Betamethasone—systemic lupus erythematosus	0.000183	0.0527	CbGdCrCtD
Gefitinib—CSNK1E—Betamethasone—Dexamethasone—systemic lupus erythematosus	0.000183	0.0527	CbGdCrCtD
Gefitinib—CSNK1E—Dexamethasone—Triamcinolone—systemic lupus erythematosus	0.000179	0.0515	CbGdCrCtD
Gefitinib—CSNK1E—Betamethasone—Triamcinolone—systemic lupus erythematosus	0.000179	0.0515	CbGdCrCtD
Gefitinib—CSNK1E—Dexamethasone—Prednisone—systemic lupus erythematosus	0.00017	0.0488	CbGdCrCtD
Gefitinib—CSNK1E—Betamethasone—Prednisone—systemic lupus erythematosus	0.00017	0.0488	CbGdCrCtD
Gefitinib—CSNK1E—Betamethasone—Prednisolone—systemic lupus erythematosus	0.000166	0.0477	CbGdCrCtD
Gefitinib—CSNK1E—Dexamethasone—Prednisolone—systemic lupus erythematosus	0.000166	0.0477	CbGdCrCtD
Gefitinib—ABCB1—kidney—systemic lupus erythematosus	0.000164	0.00182	CbGeAlD
Gefitinib—ABCB1—cortex of kidney—systemic lupus erythematosus	0.00016	0.00178	CbGeAlD
Gefitinib—CHEK2—Danazol—Hydrocortisone—systemic lupus erythematosus	0.000158	0.0455	CbGdCrCtD
Gefitinib—CYP3A4—nervous system—systemic lupus erythematosus	0.000152	0.00169	CbGeAlD
Gefitinib—CYP2D6—nervous system—systemic lupus erythematosus	0.000149	0.00166	CbGeAlD
Gefitinib—CYP3A4—central nervous system—systemic lupus erythematosus	0.000146	0.00163	CbGeAlD
Gefitinib—Arrhythmia—Betamethasone—systemic lupus erythematosus	0.000146	0.00108	CcSEcCtD
Gefitinib—Arrhythmia—Dexamethasone—systemic lupus erythematosus	0.000146	0.00108	CcSEcCtD
Gefitinib—Hypersensitivity—Leflunomide—systemic lupus erythematosus	0.000146	0.00108	CcSEcCtD
Gefitinib—Anorexia—Cyclosporine—systemic lupus erythematosus	0.000146	0.00107	CcSEcCtD
Gefitinib—Pancreatitis—Methotrexate—systemic lupus erythematosus	0.000146	0.00107	CcSEcCtD
Gefitinib—Skin disorder—Mycophenolate mofetil—systemic lupus erythematosus	0.000145	0.00107	CcSEcCtD
Gefitinib—Alopecia—Dexamethasone—systemic lupus erythematosus	0.000145	0.00106	CcSEcCtD
Gefitinib—Alopecia—Betamethasone—systemic lupus erythematosus	0.000145	0.00106	CcSEcCtD
Gefitinib—CYP2D6—central nervous system—systemic lupus erythematosus	0.000144	0.0016	CbGeAlD
Gefitinib—Diarrhoea—Azathioprine—systemic lupus erythematosus	0.000144	0.00106	CcSEcCtD
Gefitinib—Angioedema—Triamcinolone—systemic lupus erythematosus	0.000143	0.00106	CcSEcCtD
Gefitinib—Haemoglobin—Prednisone—systemic lupus erythematosus	0.000143	0.00105	CcSEcCtD
Gefitinib—Angioedema—Methylprednisolone—systemic lupus erythematosus	0.000143	0.00105	CcSEcCtD
Gefitinib—CHEK2—Norethindrone—Hydrocortisone—systemic lupus erythematosus	0.000142	0.041	CbGdCrCtD
Gefitinib—Haemorrhage—Prednisone—systemic lupus erythematosus	0.000142	0.00105	CcSEcCtD
Gefitinib—Anorexia—Mycophenolate mofetil—systemic lupus erythematosus	0.000142	0.00105	CcSEcCtD
Gefitinib—Asthenia—Leflunomide—systemic lupus erythematosus	0.000142	0.00105	CcSEcCtD
Gefitinib—Malaise—Triamcinolone—systemic lupus erythematosus	0.000142	0.00104	CcSEcCtD
Gefitinib—Malaise—Methylprednisolone—systemic lupus erythematosus	0.000141	0.00104	CcSEcCtD
Gefitinib—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—systemic lupus erythematosus	0.000141	0.00104	CcSEcCtD
Gefitinib—ABCB1—lymphoid tissue—systemic lupus erythematosus	0.000141	0.00157	CbGeAlD
Gefitinib—Pruritus—Leflunomide—systemic lupus erythematosus	0.00014	0.00103	CcSEcCtD
Gefitinib—Hypotension—Mycophenolate mofetil—systemic lupus erythematosus	0.00014	0.00103	CcSEcCtD
Gefitinib—Shock—Prednisolone—systemic lupus erythematosus	0.000137	0.00101	CcSEcCtD
Gefitinib—Cough—Triamcinolone—systemic lupus erythematosus	0.000137	0.00101	CcSEcCtD
Gefitinib—Dyspnoea—Cyclosporine—systemic lupus erythematosus	0.000136	0.001	CcSEcCtD
Gefitinib—CHEK2—Danazol—Prednisone—systemic lupus erythematosus	0.000136	0.0392	CbGdCrCtD
Gefitinib—Diarrhoea—Leflunomide—systemic lupus erythematosus	0.000136	0.000999	CcSEcCtD
Gefitinib—Infection—Hydrocortisone—systemic lupus erythematosus	0.000135	0.000995	CcSEcCtD
Gefitinib—Shock—Hydrocortisone—systemic lupus erythematosus	0.000134	0.000985	CcSEcCtD
Gefitinib—Vomiting—Azathioprine—systemic lupus erythematosus	0.000134	0.000983	CcSEcCtD
Gefitinib—Nervous system disorder—Hydrocortisone—systemic lupus erythematosus	0.000133	0.000982	CcSEcCtD
Gefitinib—Pneumonia—Methotrexate—systemic lupus erythematosus	0.000133	0.000982	CcSEcCtD
Gefitinib—Eye disorder—Prednisone—systemic lupus erythematosus	0.000133	0.00098	CcSEcCtD
Gefitinib—Dyspnoea—Mycophenolate mofetil—systemic lupus erythematosus	0.000133	0.00098	CcSEcCtD
Gefitinib—Decreased appetite—Cyclosporine—systemic lupus erythematosus	0.000133	0.00098	CcSEcCtD
Gefitinib—Infestation NOS—Methotrexate—systemic lupus erythematosus	0.000133	0.000976	CcSEcCtD
Gefitinib—Infestation—Methotrexate—systemic lupus erythematosus	0.000133	0.000976	CcSEcCtD
Gefitinib—Rash—Azathioprine—systemic lupus erythematosus	0.000132	0.000975	CcSEcCtD
Gefitinib—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—systemic lupus erythematosus	0.000132	0.000975	CcSEcCtD
Gefitinib—Dermatitis—Azathioprine—systemic lupus erythematosus	0.000132	0.000974	CcSEcCtD
Gefitinib—Gastrointestinal disorder—Cyclosporine—systemic lupus erythematosus	0.000132	0.000973	CcSEcCtD
Gefitinib—Skin disorder—Hydrocortisone—systemic lupus erythematosus	0.000132	0.000973	CcSEcCtD
Gefitinib—Fatigue—Cyclosporine—systemic lupus erythematosus	0.000132	0.000971	CcSEcCtD
Gefitinib—Stevens-Johnson syndrome—Methotrexate—systemic lupus erythematosus	0.000132	0.000968	CcSEcCtD
Gefitinib—Constipation—Cyclosporine—systemic lupus erythematosus	0.000131	0.000964	CcSEcCtD
Gefitinib—Pain—Cyclosporine—systemic lupus erythematosus	0.000131	0.000964	CcSEcCtD
Gefitinib—Dry mouth—Triamcinolone—systemic lupus erythematosus	0.000131	0.000962	CcSEcCtD
Gefitinib—Angioedema—Dexamethasone—systemic lupus erythematosus	0.00013	0.000958	CcSEcCtD
Gefitinib—Angioedema—Betamethasone—systemic lupus erythematosus	0.00013	0.000958	CcSEcCtD
Gefitinib—Decreased appetite—Mycophenolate mofetil—systemic lupus erythematosus	0.00013	0.000956	CcSEcCtD
Gefitinib—Anorexia—Hydrocortisone—systemic lupus erythematosus	0.00013	0.000955	CcSEcCtD
Gefitinib—Stomatitis—Methotrexate—systemic lupus erythematosus	0.000129	0.000952	CcSEcCtD
Gefitinib—Angiopathy—Prednisone—systemic lupus erythematosus	0.000129	0.000951	CcSEcCtD
Gefitinib—Conjunctivitis—Methotrexate—systemic lupus erythematosus	0.000129	0.000949	CcSEcCtD
Gefitinib—Gastrointestinal disorder—Mycophenolate mofetil—systemic lupus erythematosus	0.000129	0.000949	CcSEcCtD
Gefitinib—Malaise—Betamethasone—systemic lupus erythematosus	0.000128	0.000945	CcSEcCtD
Gefitinib—Malaise—Dexamethasone—systemic lupus erythematosus	0.000128	0.000945	CcSEcCtD
Gefitinib—ABCB1—bone marrow—systemic lupus erythematosus	0.000128	0.00143	CbGeAlD
Gefitinib—Pain—Mycophenolate mofetil—systemic lupus erythematosus	0.000128	0.00094	CcSEcCtD
Gefitinib—Constipation—Mycophenolate mofetil—systemic lupus erythematosus	0.000128	0.00094	CcSEcCtD
Gefitinib—Arrhythmia—Prednisone—systemic lupus erythematosus	0.000127	0.000937	CcSEcCtD
Gefitinib—Infection—Triamcinolone—systemic lupus erythematosus	0.000127	0.000937	CcSEcCtD
Gefitinib—Hypotension—Hydrocortisone—systemic lupus erythematosus	0.000127	0.000936	CcSEcCtD
Gefitinib—Infection—Methylprednisolone—systemic lupus erythematosus	0.000127	0.000935	CcSEcCtD
Gefitinib—Haematuria—Methotrexate—systemic lupus erythematosus	0.000126	0.000931	CcSEcCtD
Gefitinib—Vomiting—Leflunomide—systemic lupus erythematosus	0.000126	0.000928	CcSEcCtD
Gefitinib—Shock—Triamcinolone—systemic lupus erythematosus	0.000126	0.000928	CcSEcCtD
Gefitinib—Alopecia—Prednisone—systemic lupus erythematosus	0.000126	0.000927	CcSEcCtD
Gefitinib—Shock—Methylprednisolone—systemic lupus erythematosus	0.000126	0.000926	CcSEcCtD
Gefitinib—Hepatobiliary disease—Methotrexate—systemic lupus erythematosus	0.000125	0.000923	CcSEcCtD
Gefitinib—Nervous system disorder—Methylprednisolone—systemic lupus erythematosus	0.000125	0.000923	CcSEcCtD
Gefitinib—Gastrointestinal pain—Cyclosporine—systemic lupus erythematosus	0.000125	0.000921	CcSEcCtD
Gefitinib—Epistaxis—Methotrexate—systemic lupus erythematosus	0.000125	0.000921	CcSEcCtD
Gefitinib—Rash—Leflunomide—systemic lupus erythematosus	0.000125	0.000921	CcSEcCtD
Gefitinib—Dermatitis—Leflunomide—systemic lupus erythematosus	0.000125	0.00092	CcSEcCtD
Gefitinib—Nausea—Azathioprine—systemic lupus erythematosus	0.000125	0.000918	CcSEcCtD
Gefitinib—Skin disorder—Methylprednisolone—systemic lupus erythematosus	0.000124	0.000914	CcSEcCtD
Gefitinib—Malnutrition—Prednisone—systemic lupus erythematosus	0.000124	0.000913	CcSEcCtD
Gefitinib—Gastrointestinal pain—Mycophenolate mofetil—systemic lupus erythematosus	0.000122	0.000899	CcSEcCtD
Gefitinib—Urticaria—Cyclosporine—systemic lupus erythematosus	0.000122	0.000895	CcSEcCtD
Gefitinib—Abdominal pain—Cyclosporine—systemic lupus erythematosus	0.000121	0.000891	CcSEcCtD
Gefitinib—Body temperature increased—Cyclosporine—systemic lupus erythematosus	0.000121	0.000891	CcSEcCtD
Gefitinib—Erlotinib—ALB—systemic lupus erythematosus	0.00012	0.0149	CrCbGaD
Gefitinib—Haemoglobin—Methotrexate—systemic lupus erythematosus	0.00012	0.000881	CcSEcCtD
Gefitinib—Hypotension—Methylprednisolone—systemic lupus erythematosus	0.000119	0.000879	CcSEcCtD
Gefitinib—Pain—Prednisolone—systemic lupus erythematosus	0.000119	0.000877	CcSEcCtD
Gefitinib—Haemorrhage—Methotrexate—systemic lupus erythematosus	0.000119	0.000876	CcSEcCtD
Gefitinib—Hepatitis—Methotrexate—systemic lupus erythematosus	0.000119	0.000876	CcSEcCtD
Gefitinib—Urticaria—Mycophenolate mofetil—systemic lupus erythematosus	0.000119	0.000873	CcSEcCtD
Gefitinib—Decreased appetite—Hydrocortisone—systemic lupus erythematosus	0.000118	0.000871	CcSEcCtD
Gefitinib—Abdominal pain—Mycophenolate mofetil—systemic lupus erythematosus	0.000118	0.000869	CcSEcCtD
Gefitinib—Body temperature increased—Mycophenolate mofetil—systemic lupus erythematosus	0.000118	0.000869	CcSEcCtD
Gefitinib—Nausea—Leflunomide—systemic lupus erythematosus	0.000118	0.000867	CcSEcCtD
Gefitinib—Urinary tract disorder—Methotrexate—systemic lupus erythematosus	0.000118	0.000866	CcSEcCtD
Gefitinib—Gastrointestinal disorder—Hydrocortisone—systemic lupus erythematosus	0.000117	0.000865	CcSEcCtD
Gefitinib—Fatigue—Hydrocortisone—systemic lupus erythematosus	0.000117	0.000863	CcSEcCtD
Gefitinib—Urethral disorder—Methotrexate—systemic lupus erythematosus	0.000117	0.000859	CcSEcCtD
Gefitinib—Pain—Hydrocortisone—systemic lupus erythematosus	0.000116	0.000856	CcSEcCtD
Gefitinib—ABCB1—lung—systemic lupus erythematosus	0.000116	0.00129	CbGeAlD
Gefitinib—Infection—Dexamethasone—systemic lupus erythematosus	0.000115	0.00085	CcSEcCtD
Gefitinib—Infection—Betamethasone—systemic lupus erythematosus	0.000115	0.00085	CcSEcCtD
Gefitinib—Anaemia—Prednisone—systemic lupus erythematosus	0.000115	0.000844	CcSEcCtD
Gefitinib—Shock—Betamethasone—systemic lupus erythematosus	0.000114	0.000842	CcSEcCtD
Gefitinib—Shock—Dexamethasone—systemic lupus erythematosus	0.000114	0.000842	CcSEcCtD
Gefitinib—Dyspnoea—Triamcinolone—systemic lupus erythematosus	0.000114	0.000841	CcSEcCtD
Gefitinib—Nervous system disorder—Dexamethasone—systemic lupus erythematosus	0.000114	0.000839	CcSEcCtD
Gefitinib—Nervous system disorder—Betamethasone—systemic lupus erythematosus	0.000114	0.000839	CcSEcCtD
Gefitinib—Thrombocytopenia—Betamethasone—systemic lupus erythematosus	0.000114	0.000838	CcSEcCtD
Gefitinib—Thrombocytopenia—Dexamethasone—systemic lupus erythematosus	0.000114	0.000838	CcSEcCtD
Gefitinib—CHEK2—Levonorgestrel—Hydrocortisone—systemic lupus erythematosus	0.000113	0.0326	CbGdCrCtD
Gefitinib—Angioedema—Prednisone—systemic lupus erythematosus	0.000113	0.000834	CcSEcCtD
Gefitinib—Hypersensitivity—Cyclosporine—systemic lupus erythematosus	0.000113	0.00083	CcSEcCtD
Gefitinib—Erythema multiforme—Methotrexate—systemic lupus erythematosus	0.000113	0.000829	CcSEcCtD
Gefitinib—Malaise—Prednisone—systemic lupus erythematosus	0.000112	0.000823	CcSEcCtD
Gefitinib—Eye disorder—Methotrexate—systemic lupus erythematosus	0.000111	0.000819	CcSEcCtD
Gefitinib—Gastrointestinal pain—Hydrocortisone—systemic lupus erythematosus	0.000111	0.000819	CcSEcCtD
Gefitinib—Anorexia—Betamethasone—systemic lupus erythematosus	0.000111	0.000816	CcSEcCtD
Gefitinib—Anorexia—Dexamethasone—systemic lupus erythematosus	0.000111	0.000816	CcSEcCtD
Gefitinib—Urticaria—Prednisolone—systemic lupus erythematosus	0.000111	0.000815	CcSEcCtD
Gefitinib—Cardiac disorder—Methotrexate—systemic lupus erythematosus	0.000111	0.000813	CcSEcCtD
Gefitinib—Fatigue—Triamcinolone—systemic lupus erythematosus	0.00011	0.000813	CcSEcCtD
Gefitinib—Fatigue—Methylprednisolone—systemic lupus erythematosus	0.00011	0.000811	CcSEcCtD
Gefitinib—Hypersensitivity—Mycophenolate mofetil—systemic lupus erythematosus	0.00011	0.00081	CcSEcCtD
Gefitinib—Asthenia—Cyclosporine—systemic lupus erythematosus	0.00011	0.000808	CcSEcCtD
Gefitinib—Pain—Triamcinolone—systemic lupus erythematosus	0.00011	0.000806	CcSEcCtD
Gefitinib—Hypotension—Dexamethasone—systemic lupus erythematosus	0.000109	0.000799	CcSEcCtD
Gefitinib—Hypotension—Betamethasone—systemic lupus erythematosus	0.000109	0.000799	CcSEcCtD
Gefitinib—Pruritus—Cyclosporine—systemic lupus erythematosus	0.000108	0.000797	CcSEcCtD
Gefitinib—Urticaria—Hydrocortisone—systemic lupus erythematosus	0.000108	0.000796	CcSEcCtD
Gefitinib—Angiopathy—Methotrexate—systemic lupus erythematosus	0.000108	0.000795	CcSEcCtD
Gefitinib—Body temperature increased—Hydrocortisone—systemic lupus erythematosus	0.000108	0.000792	CcSEcCtD
Gefitinib—Abdominal pain—Hydrocortisone—systemic lupus erythematosus	0.000108	0.000792	CcSEcCtD
Gefitinib—ABCB1—nervous system—systemic lupus erythematosus	0.000108	0.0012	CbGeAlD
Gefitinib—Mediastinal disorder—Methotrexate—systemic lupus erythematosus	0.000107	0.00079	CcSEcCtD
Gefitinib—Asthenia—Mycophenolate mofetil—systemic lupus erythematosus	0.000107	0.000789	CcSEcCtD
Gefitinib—Pruritus—Mycophenolate mofetil—systemic lupus erythematosus	0.000106	0.000778	CcSEcCtD
Gefitinib—Alopecia—Methotrexate—systemic lupus erythematosus	0.000105	0.000774	CcSEcCtD
Gefitinib—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic lupus erythematosus	0.000105	0.000772	CcSEcCtD
Gefitinib—Diarrhoea—Cyclosporine—systemic lupus erythematosus	0.000105	0.000771	CcSEcCtD
Gefitinib—Gastrointestinal pain—Methylprednisolone—systemic lupus erythematosus	0.000105	0.000769	CcSEcCtD
Gefitinib—Malnutrition—Methotrexate—systemic lupus erythematosus	0.000104	0.000763	CcSEcCtD
Gefitinib—ABCB1—central nervous system—systemic lupus erythematosus	0.000104	0.00115	CbGeAlD
Gefitinib—Hypersensitivity—Prednisolone—systemic lupus erythematosus	0.000103	0.000755	CcSEcCtD
Gefitinib—Diarrhoea—Mycophenolate mofetil—systemic lupus erythematosus	0.000102	0.000752	CcSEcCtD
Gefitinib—Urticaria—Triamcinolone—systemic lupus erythematosus	0.000102	0.000749	CcSEcCtD
Gefitinib—Urticaria—Methylprednisolone—systemic lupus erythematosus	0.000102	0.000747	CcSEcCtD
Gefitinib—Body temperature increased—Triamcinolone—systemic lupus erythematosus	0.000101	0.000745	CcSEcCtD
Gefitinib—Abdominal pain—Methylprednisolone—systemic lupus erythematosus	0.000101	0.000744	CcSEcCtD
Gefitinib—Decreased appetite—Dexamethasone—systemic lupus erythematosus	0.000101	0.000744	CcSEcCtD
Gefitinib—Decreased appetite—Betamethasone—systemic lupus erythematosus	0.000101	0.000744	CcSEcCtD
Gefitinib—Infection—Prednisone—systemic lupus erythematosus	0.000101	0.00074	CcSEcCtD
Gefitinib—Gastrointestinal disorder—Dexamethasone—systemic lupus erythematosus	0.0001	0.000739	CcSEcCtD
Gefitinib—Gastrointestinal disorder—Betamethasone—systemic lupus erythematosus	0.0001	0.000739	CcSEcCtD
Gefitinib—Hypersensitivity—Hydrocortisone—systemic lupus erythematosus	0.0001	0.000738	CcSEcCtD
Gefitinib—Fatigue—Dexamethasone—systemic lupus erythematosus	0.0001	0.000738	CcSEcCtD
Gefitinib—Fatigue—Betamethasone—systemic lupus erythematosus	0.0001	0.000738	CcSEcCtD
Gefitinib—Shock—Prednisone—systemic lupus erythematosus	9.96e-05	0.000733	CcSEcCtD
Gefitinib—Pain—Betamethasone—systemic lupus erythematosus	9.94e-05	0.000732	CcSEcCtD
Gefitinib—Pain—Dexamethasone—systemic lupus erythematosus	9.94e-05	0.000732	CcSEcCtD
Gefitinib—Nervous system disorder—Prednisone—systemic lupus erythematosus	9.93e-05	0.000731	CcSEcCtD
Gefitinib—Skin disorder—Prednisone—systemic lupus erythematosus	9.83e-05	0.000724	CcSEcCtD
Gefitinib—Asthenia—Hydrocortisone—systemic lupus erythematosus	9.76e-05	0.000718	CcSEcCtD
Gefitinib—Vomiting—Cyclosporine—systemic lupus erythematosus	9.73e-05	0.000716	CcSEcCtD
Gefitinib—Rash—Cyclosporine—systemic lupus erythematosus	9.65e-05	0.00071	CcSEcCtD
Gefitinib—Anorexia—Prednisone—systemic lupus erythematosus	9.65e-05	0.00071	CcSEcCtD
Gefitinib—Dermatitis—Cyclosporine—systemic lupus erythematosus	9.64e-05	0.00071	CcSEcCtD
Gefitinib—Pruritus—Hydrocortisone—systemic lupus erythematosus	9.63e-05	0.000708	CcSEcCtD
Gefitinib—Anaemia—Methotrexate—systemic lupus erythematosus	9.58e-05	0.000705	CcSEcCtD
Gefitinib—Gastrointestinal pain—Betamethasone—systemic lupus erythematosus	9.5e-05	0.0007	CcSEcCtD
Gefitinib—Gastrointestinal pain—Dexamethasone—systemic lupus erythematosus	9.5e-05	0.0007	CcSEcCtD
Gefitinib—Vomiting—Mycophenolate mofetil—systemic lupus erythematosus	9.49e-05	0.000699	CcSEcCtD
Gefitinib—Hypersensitivity—Triamcinolone—systemic lupus erythematosus	9.44e-05	0.000695	CcSEcCtD
Gefitinib—Hypersensitivity—Methylprednisolone—systemic lupus erythematosus	9.42e-05	0.000693	CcSEcCtD
Gefitinib—Rash—Mycophenolate mofetil—systemic lupus erythematosus	9.42e-05	0.000693	CcSEcCtD
Gefitinib—Dermatitis—Mycophenolate mofetil—systemic lupus erythematosus	9.41e-05	0.000692	CcSEcCtD
Gefitinib—Malaise—Methotrexate—systemic lupus erythematosus	9.35e-05	0.000688	CcSEcCtD
Gefitinib—Diarrhoea—Hydrocortisone—systemic lupus erythematosus	9.31e-05	0.000685	CcSEcCtD
Gefitinib—Urticaria—Dexamethasone—systemic lupus erythematosus	9.23e-05	0.00068	CcSEcCtD
Gefitinib—Urticaria—Betamethasone—systemic lupus erythematosus	9.23e-05	0.00068	CcSEcCtD
Gefitinib—Asthenia—Triamcinolone—systemic lupus erythematosus	9.19e-05	0.000677	CcSEcCtD
Gefitinib—Body temperature increased—Dexamethasone—systemic lupus erythematosus	9.19e-05	0.000676	CcSEcCtD
Gefitinib—Abdominal pain—Dexamethasone—systemic lupus erythematosus	9.19e-05	0.000676	CcSEcCtD
Gefitinib—Abdominal pain—Betamethasone—systemic lupus erythematosus	9.19e-05	0.000676	CcSEcCtD
Gefitinib—Body temperature increased—Betamethasone—systemic lupus erythematosus	9.19e-05	0.000676	CcSEcCtD
Gefitinib—Asthenia—Methylprednisolone—systemic lupus erythematosus	9.17e-05	0.000675	CcSEcCtD
Gefitinib—Nausea—Cyclosporine—systemic lupus erythematosus	9.09e-05	0.000669	CcSEcCtD
Gefitinib—Pruritus—Triamcinolone—systemic lupus erythematosus	9.06e-05	0.000667	CcSEcCtD
Gefitinib—Cough—Methotrexate—systemic lupus erythematosus	9.05e-05	0.000666	CcSEcCtD
Gefitinib—Pruritus—Methylprednisolone—systemic lupus erythematosus	9.04e-05	0.000666	CcSEcCtD
Gefitinib—Nausea—Mycophenolate mofetil—systemic lupus erythematosus	8.87e-05	0.000653	CcSEcCtD
Gefitinib—Decreased appetite—Prednisone—systemic lupus erythematosus	8.8e-05	0.000648	CcSEcCtD
Gefitinib—Rash—Prednisolone—systemic lupus erythematosus	8.78e-05	0.000646	CcSEcCtD
Gefitinib—Dermatitis—Prednisolone—systemic lupus erythematosus	8.78e-05	0.000646	CcSEcCtD
Gefitinib—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic lupus erythematosus	8.76e-05	0.000645	CcSEcCtD
Gefitinib—Diarrhoea—Methylprednisolone—systemic lupus erythematosus	8.75e-05	0.000644	CcSEcCtD
Gefitinib—Fatigue—Prednisone—systemic lupus erythematosus	8.73e-05	0.000642	CcSEcCtD
Gefitinib—Constipation—Prednisone—systemic lupus erythematosus	8.66e-05	0.000637	CcSEcCtD
Gefitinib—Vomiting—Hydrocortisone—systemic lupus erythematosus	8.65e-05	0.000637	CcSEcCtD
Gefitinib—Rash—Hydrocortisone—systemic lupus erythematosus	8.58e-05	0.000631	CcSEcCtD
Gefitinib—Dermatitis—Hydrocortisone—systemic lupus erythematosus	8.57e-05	0.000631	CcSEcCtD
Gefitinib—Infection—Methotrexate—systemic lupus erythematosus	8.4e-05	0.000619	CcSEcCtD
Gefitinib—Asthenia—Betamethasone—systemic lupus erythematosus	8.34e-05	0.000614	CcSEcCtD
Gefitinib—Asthenia—Dexamethasone—systemic lupus erythematosus	8.34e-05	0.000614	CcSEcCtD
Gefitinib—Nervous system disorder—Methotrexate—systemic lupus erythematosus	8.3e-05	0.000611	CcSEcCtD
Gefitinib—Thrombocytopenia—Methotrexate—systemic lupus erythematosus	8.28e-05	0.00061	CcSEcCtD
Gefitinib—Gastrointestinal pain—Prednisone—systemic lupus erythematosus	8.28e-05	0.000609	CcSEcCtD
Gefitinib—Nausea—Prednisolone—systemic lupus erythematosus	8.27e-05	0.000609	CcSEcCtD
Gefitinib—Pruritus—Betamethasone—systemic lupus erythematosus	8.22e-05	0.000605	CcSEcCtD
Gefitinib—Pruritus—Dexamethasone—systemic lupus erythematosus	8.22e-05	0.000605	CcSEcCtD
Gefitinib—Skin disorder—Methotrexate—systemic lupus erythematosus	8.22e-05	0.000605	CcSEcCtD
Gefitinib—Vomiting—Triamcinolone—systemic lupus erythematosus	8.15e-05	0.0006	CcSEcCtD
Gefitinib—Vomiting—Methylprednisolone—systemic lupus erythematosus	8.13e-05	0.000598	CcSEcCtD
Gefitinib—Nausea—Hydrocortisone—systemic lupus erythematosus	8.08e-05	0.000595	CcSEcCtD
Gefitinib—Rash—Triamcinolone—systemic lupus erythematosus	8.08e-05	0.000595	CcSEcCtD
Gefitinib—Dermatitis—Triamcinolone—systemic lupus erythematosus	8.07e-05	0.000594	CcSEcCtD
Gefitinib—Anorexia—Methotrexate—systemic lupus erythematosus	8.06e-05	0.000594	CcSEcCtD
Gefitinib—Rash—Methylprednisolone—systemic lupus erythematosus	8.06e-05	0.000593	CcSEcCtD
Gefitinib—Dermatitis—Methylprednisolone—systemic lupus erythematosus	8.05e-05	0.000593	CcSEcCtD
Gefitinib—Urticaria—Prednisone—systemic lupus erythematosus	8.04e-05	0.000592	CcSEcCtD
Gefitinib—Abdominal pain—Prednisone—systemic lupus erythematosus	8e-05	0.000589	CcSEcCtD
Gefitinib—Body temperature increased—Prednisone—systemic lupus erythematosus	8e-05	0.000589	CcSEcCtD
Gefitinib—Diarrhoea—Dexamethasone—systemic lupus erythematosus	7.95e-05	0.000585	CcSEcCtD
Gefitinib—Diarrhoea—Betamethasone—systemic lupus erythematosus	7.95e-05	0.000585	CcSEcCtD
Gefitinib—Hypotension—Methotrexate—systemic lupus erythematosus	7.91e-05	0.000582	CcSEcCtD
Gefitinib—Vandetanib—ALB—systemic lupus erythematosus	7.9e-05	0.00983	CrCbGaD
Gefitinib—Nausea—Triamcinolone—systemic lupus erythematosus	7.61e-05	0.00056	CcSEcCtD
Gefitinib—Nausea—Methylprednisolone—systemic lupus erythematosus	7.59e-05	0.000559	CcSEcCtD
Gefitinib—Dyspnoea—Methotrexate—systemic lupus erythematosus	7.54e-05	0.000555	CcSEcCtD
Gefitinib—Hypersensitivity—Prednisone—systemic lupus erythematosus	7.46e-05	0.000549	CcSEcCtD
Gefitinib—Vomiting—Dexamethasone—systemic lupus erythematosus	7.39e-05	0.000544	CcSEcCtD
Gefitinib—Vomiting—Betamethasone—systemic lupus erythematosus	7.39e-05	0.000544	CcSEcCtD
Gefitinib—Decreased appetite—Methotrexate—systemic lupus erythematosus	7.35e-05	0.000541	CcSEcCtD
Gefitinib—Rash—Dexamethasone—systemic lupus erythematosus	7.33e-05	0.000539	CcSEcCtD
Gefitinib—Rash—Betamethasone—systemic lupus erythematosus	7.33e-05	0.000539	CcSEcCtD
Gefitinib—Dermatitis—Betamethasone—systemic lupus erythematosus	7.32e-05	0.000539	CcSEcCtD
Gefitinib—Dermatitis—Dexamethasone—systemic lupus erythematosus	7.32e-05	0.000539	CcSEcCtD
Gefitinib—Gastrointestinal disorder—Methotrexate—systemic lupus erythematosus	7.3e-05	0.000538	CcSEcCtD
Gefitinib—Fatigue—Methotrexate—systemic lupus erythematosus	7.29e-05	0.000537	CcSEcCtD
Gefitinib—Asthenia—Prednisone—systemic lupus erythematosus	7.26e-05	0.000535	CcSEcCtD
Gefitinib—Pain—Methotrexate—systemic lupus erythematosus	7.23e-05	0.000532	CcSEcCtD
Gefitinib—Pruritus—Prednisone—systemic lupus erythematosus	7.16e-05	0.000527	CcSEcCtD
Gefitinib—Diarrhoea—Prednisone—systemic lupus erythematosus	6.93e-05	0.00051	CcSEcCtD
Gefitinib—Gastrointestinal pain—Methotrexate—systemic lupus erythematosus	6.92e-05	0.000509	CcSEcCtD
Gefitinib—Nausea—Dexamethasone—systemic lupus erythematosus	6.9e-05	0.000508	CcSEcCtD
Gefitinib—Nausea—Betamethasone—systemic lupus erythematosus	6.9e-05	0.000508	CcSEcCtD
Gefitinib—Urticaria—Methotrexate—systemic lupus erythematosus	6.72e-05	0.000495	CcSEcCtD
Gefitinib—Abdominal pain—Methotrexate—systemic lupus erythematosus	6.69e-05	0.000492	CcSEcCtD
Gefitinib—Body temperature increased—Methotrexate—systemic lupus erythematosus	6.69e-05	0.000492	CcSEcCtD
Gefitinib—Vomiting—Prednisone—systemic lupus erythematosus	6.44e-05	0.000474	CcSEcCtD
Gefitinib—Rash—Prednisone—systemic lupus erythematosus	6.38e-05	0.00047	CcSEcCtD
Gefitinib—Dermatitis—Prednisone—systemic lupus erythematosus	6.38e-05	0.000469	CcSEcCtD
Gefitinib—Hypersensitivity—Methotrexate—systemic lupus erythematosus	6.23e-05	0.000459	CcSEcCtD
Gefitinib—Asthenia—Methotrexate—systemic lupus erythematosus	6.07e-05	0.000447	CcSEcCtD
Gefitinib—Nausea—Prednisone—systemic lupus erythematosus	6.01e-05	0.000443	CcSEcCtD
Gefitinib—Pruritus—Methotrexate—systemic lupus erythematosus	5.99e-05	0.000441	CcSEcCtD
Gefitinib—Diarrhoea—Methotrexate—systemic lupus erythematosus	5.79e-05	0.000426	CcSEcCtD
Gefitinib—Vomiting—Methotrexate—systemic lupus erythematosus	5.38e-05	0.000396	CcSEcCtD
Gefitinib—Rash—Methotrexate—systemic lupus erythematosus	5.33e-05	0.000393	CcSEcCtD
Gefitinib—Dermatitis—Methotrexate—systemic lupus erythematosus	5.33e-05	0.000392	CcSEcCtD
Gefitinib—Nausea—Methotrexate—systemic lupus erythematosus	5.02e-05	0.00037	CcSEcCtD
Gefitinib—ABCG2—Transmembrane transport of small molecules—ALB—systemic lupus erythematosus	9.71e-06	7.17e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling by GPCR—CCR5—systemic lupus erythematosus	9.68e-06	7.15e-05	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism—NAT2—systemic lupus erythematosus	9.67e-06	7.15e-05	CbGpPWpGaD
Gefitinib—EGFR—Immune System—CD8A—systemic lupus erythematosus	9.67e-06	7.14e-05	CbGpPWpGaD
Gefitinib—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—systemic lupus erythematosus	9.62e-06	7.11e-05	CbGpPWpGaD
Gefitinib—ALB—Hemostasis—IL2RA—systemic lupus erythematosus	9.57e-06	7.07e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling by GPCR—IL2RA—systemic lupus erythematosus	9.54e-06	7.05e-05	CbGpPWpGaD
Gefitinib—EGFR—Innate Immune System—CD4—systemic lupus erythematosus	9.53e-06	7.04e-05	CbGpPWpGaD
Gefitinib—MKNK1—Signaling Pathways—MMP9—systemic lupus erythematosus	9.48e-06	7e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling by GPCR—C3—systemic lupus erythematosus	9.46e-06	6.99e-05	CbGpPWpGaD
Gefitinib—MKNK1—Signaling Pathways—CDKN1A—systemic lupus erythematosus	9.44e-06	6.98e-05	CbGpPWpGaD
Gefitinib—EGFR—Developmental Biology—MMP9—systemic lupus erythematosus	9.4e-06	6.95e-05	CbGpPWpGaD
Gefitinib—ERBB3—Immune System—CDKN1B—systemic lupus erythematosus	9.38e-06	6.93e-05	CbGpPWpGaD
Gefitinib—CSNK1E—Signaling Pathways—TYK2—systemic lupus erythematosus	9.36e-06	6.91e-05	CbGpPWpGaD
Gefitinib—EGFR—Immune System—JAK1—systemic lupus erythematosus	9.33e-06	6.89e-05	CbGpPWpGaD
Gefitinib—ERBB3—Innate Immune System—IL6—systemic lupus erythematosus	9.26e-06	6.84e-05	CbGpPWpGaD
Gefitinib—ALB—Platelet activation, signaling and aggregation—VEGFA—systemic lupus erythematosus	9.25e-06	6.84e-05	CbGpPWpGaD
Gefitinib—ABCB1—Transmembrane transport of small molecules—RXRA—systemic lupus erythematosus	9.25e-06	6.83e-05	CbGpPWpGaD
Gefitinib—ERBB3—Disease—CD4—systemic lupus erythematosus	9.21e-06	6.8e-05	CbGpPWpGaD
Gefitinib—CSNK1E—Signaling Pathways—NOS3—systemic lupus erythematosus	9.18e-06	6.79e-05	CbGpPWpGaD
Gefitinib—IRAK1—Immune System—TYK2—systemic lupus erythematosus	9.18e-06	6.78e-05	CbGpPWpGaD
Gefitinib—ERBB3—Immune System—IL2—systemic lupus erythematosus	9.18e-06	6.78e-05	CbGpPWpGaD
Gefitinib—EGFR—Adaptive Immune System—CD4—systemic lupus erythematosus	9.15e-06	6.76e-05	CbGpPWpGaD
Gefitinib—ERBB3—Disease—PTGS2—systemic lupus erythematosus	9.14e-06	6.75e-05	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—F2—systemic lupus erythematosus	9.14e-06	6.75e-05	CbGpPWpGaD
Gefitinib—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—systemic lupus erythematosus	9.11e-06	6.73e-05	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism of lipids and lipoproteins—RXRA—systemic lupus erythematosus	9.08e-06	6.71e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling by NGF—IL6—systemic lupus erythematosus	9.04e-06	6.68e-05	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—JAK1—systemic lupus erythematosus	9.02e-06	6.67e-05	CbGpPWpGaD
Gefitinib—MKNK1—Signaling Pathways—EP300—systemic lupus erythematosus	8.98e-06	6.64e-05	CbGpPWpGaD
Gefitinib—EGFR—Innate Immune System—CDKN1B—systemic lupus erythematosus	8.96e-06	6.62e-05	CbGpPWpGaD
Gefitinib—EGFR—Developmental Biology—EP300—systemic lupus erythematosus	8.91e-06	6.58e-05	CbGpPWpGaD
Gefitinib—ALB—Metabolism—NAT2—systemic lupus erythematosus	8.82e-06	6.52e-05	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—F2—systemic lupus erythematosus	8.81e-06	6.51e-05	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—CD80—systemic lupus erythematosus	8.76e-06	6.47e-05	CbGpPWpGaD
Gefitinib—EGFR—Immune System—IL2RA—systemic lupus erythematosus	8.71e-06	6.44e-05	CbGpPWpGaD
Gefitinib—CSNK1E—Disease—TGFB1—systemic lupus erythematosus	8.67e-06	6.41e-05	CbGpPWpGaD
Gefitinib—ERBB3—Disease—CDKN1B—systemic lupus erythematosus	8.66e-06	6.4e-05	CbGpPWpGaD
Gefitinib—ERBB3—Immune System—CDKN1A—systemic lupus erythematosus	8.65e-06	6.39e-05	CbGpPWpGaD
Gefitinib—EGFR—Immune System—C3—systemic lupus erythematosus	8.64e-06	6.38e-05	CbGpPWpGaD
Gefitinib—EGFR—Disease—JAK1—systemic lupus erythematosus	8.61e-06	6.37e-05	CbGpPWpGaD
Gefitinib—EGFR—Adaptive Immune System—CDKN1B—systemic lupus erythematosus	8.61e-06	6.36e-05	CbGpPWpGaD
Gefitinib—IRAK1—Immune System—IFNG—systemic lupus erythematosus	8.6e-06	6.35e-05	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—CCR5—systemic lupus erythematosus	8.55e-06	6.32e-05	CbGpPWpGaD
Gefitinib—MKNK1—Signaling Pathways—VEGFA—systemic lupus erythematosus	8.51e-06	6.29e-05	CbGpPWpGaD
Gefitinib—ALB—Platelet activation, signaling and aggregation—TGFB1—systemic lupus erythematosus	8.49e-06	6.28e-05	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—CD80—systemic lupus erythematosus	8.45e-06	6.24e-05	CbGpPWpGaD
Gefitinib—EGFR—Developmental Biology—VEGFA—systemic lupus erythematosus	8.44e-06	6.24e-05	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—IL2RA—systemic lupus erythematosus	8.42e-06	6.23e-05	CbGpPWpGaD
Gefitinib—MKNK1—Disease—IL6—systemic lupus erythematosus	8.4e-06	6.21e-05	CbGpPWpGaD
Gefitinib—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—systemic lupus erythematosus	8.36e-06	6.18e-05	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—C3—systemic lupus erythematosus	8.35e-06	6.17e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—CXCL12—systemic lupus erythematosus	8.34e-06	6.16e-05	CbGpPWpGaD
Gefitinib—ALB—Hemostasis—F2—systemic lupus erythematosus	8.33e-06	6.16e-05	CbGpPWpGaD
Gefitinib—IRAK1—Immune System—CD4—systemic lupus erythematosus	8.3e-06	6.14e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling by GPCR—F2—systemic lupus erythematosus	8.3e-06	6.13e-05	CbGpPWpGaD
Gefitinib—EGFR—Innate Immune System—CDKN1A—systemic lupus erythematosus	8.27e-06	6.11e-05	CbGpPWpGaD
Gefitinib—ERBB3—Immune System—EP300—systemic lupus erythematosus	8.23e-06	6.08e-05	CbGpPWpGaD
Gefitinib—EGFR—Immune System—CRP—systemic lupus erythematosus	8.22e-06	6.07e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—JUNB—systemic lupus erythematosus	8.19e-06	6.05e-05	CbGpPWpGaD
Gefitinib—EGFR—Axon guidance—IL6—systemic lupus erythematosus	8.18e-06	6.04e-05	CbGpPWpGaD
Gefitinib—EGFR—Disease—CCR5—systemic lupus erythematosus	8.16e-06	6.03e-05	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—CCL2—systemic lupus erythematosus	8.15e-06	6.02e-05	CbGpPWpGaD
Gefitinib—ABCG2—Metabolism—RXRA—systemic lupus erythematosus	8.01e-06	5.92e-05	CbGpPWpGaD
Gefitinib—ERBB3—Disease—CDKN1A—systemic lupus erythematosus	7.99e-06	5.9e-05	CbGpPWpGaD
Gefitinib—CSNK1E—Signaling Pathways—CDKN1B—systemic lupus erythematosus	7.96e-06	5.88e-05	CbGpPWpGaD
Gefitinib—EGFR—Adaptive Immune System—CDKN1A—systemic lupus erythematosus	7.94e-06	5.87e-05	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—NAT2—systemic lupus erythematosus	7.91e-06	5.85e-05	CbGpPWpGaD
Gefitinib—EGFR—Immune System—TLR4—systemic lupus erythematosus	7.88e-06	5.82e-05	CbGpPWpGaD
Gefitinib—EGFR—Immune System—HLA-DRB1—systemic lupus erythematosus	7.87e-06	5.82e-05	CbGpPWpGaD
Gefitinib—EGFR—Innate Immune System—EP300—systemic lupus erythematosus	7.87e-06	5.82e-05	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—CCL2—systemic lupus erythematosus	7.85e-06	5.8e-05	CbGpPWpGaD
Gefitinib—MKNK1—Signaling Pathways—TGFB1—systemic lupus erythematosus	7.81e-06	5.77e-05	CbGpPWpGaD
Gefitinib—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—systemic lupus erythematosus	7.81e-06	5.77e-05	CbGpPWpGaD
Gefitinib—IRAK1—Immune System—CDKN1B—systemic lupus erythematosus	7.81e-06	5.77e-05	CbGpPWpGaD
Gefitinib—CSNK1E—Signaling Pathways—IL2—systemic lupus erythematosus	7.79e-06	5.75e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—RASGRP1—systemic lupus erythematosus	7.78e-06	5.75e-05	CbGpPWpGaD
Gefitinib—EGFR—Developmental Biology—TGFB1—systemic lupus erythematosus	7.75e-06	5.72e-05	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—NAT2—systemic lupus erythematosus	7.72e-06	5.71e-05	CbGpPWpGaD
Gefitinib—IRAK1—Innate Immune System—IL6—systemic lupus erythematosus	7.71e-06	5.7e-05	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism of lipids and lipoproteins—PPARG—systemic lupus erythematosus	7.69e-06	5.68e-05	CbGpPWpGaD
Gefitinib—IRAK1—Immune System—IL2—systemic lupus erythematosus	7.64e-06	5.65e-05	CbGpPWpGaD
Gefitinib—ERBB3—Disease—EP300—systemic lupus erythematosus	7.6e-06	5.62e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—PRL—systemic lupus erythematosus	7.54e-06	5.57e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling by GPCR—CCL2—systemic lupus erythematosus	7.4e-06	5.47e-05	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—TYK2—systemic lupus erythematosus	7.4e-06	5.47e-05	CbGpPWpGaD
Gefitinib—CSNK1E—Signaling Pathways—MMP9—systemic lupus erythematosus	7.37e-06	5.45e-05	CbGpPWpGaD
Gefitinib—CSNK1E—Signaling Pathways—CDKN1A—systemic lupus erythematosus	7.34e-06	5.43e-05	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—F2—systemic lupus erythematosus	7.33e-06	5.42e-05	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—NAT2—systemic lupus erythematosus	7.28e-06	5.38e-05	CbGpPWpGaD
Gefitinib—EGFR—Immune System—CD80—systemic lupus erythematosus	7.27e-06	5.37e-05	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—NOS3—systemic lupus erythematosus	7.26e-06	5.37e-05	CbGpPWpGaD
Gefitinib—EGFR—Developmental Biology—TNF—systemic lupus erythematosus	7.23e-06	5.35e-05	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—NAT2—systemic lupus erythematosus	7.22e-06	5.33e-05	CbGpPWpGaD
Gefitinib—IRAK1—Immune System—CDKN1A—systemic lupus erythematosus	7.2e-06	5.32e-05	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—TYK2—systemic lupus erythematosus	7.13e-06	5.27e-05	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—CD80—systemic lupus erythematosus	7.03e-06	5.2e-05	CbGpPWpGaD
Gefitinib—ALB—Metabolism of lipids and lipoproteins—PPARG—systemic lupus erythematosus	7.01e-06	5.18e-05	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—NOS3—systemic lupus erythematosus	7e-06	5.17e-05	CbGpPWpGaD
Gefitinib—CSNK1E—Signaling Pathways—EP300—systemic lupus erythematosus	6.99e-06	5.16e-05	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism of lipids and lipoproteins—ALB—systemic lupus erythematosus	6.91e-06	5.11e-05	CbGpPWpGaD
Gefitinib—IRAK1—Immune System—EP300—systemic lupus erythematosus	6.85e-06	5.07e-05	CbGpPWpGaD
Gefitinib—IRAK4—Immune System—IL6—systemic lupus erythematosus	6.76e-06	5e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling by GPCR—TYK2—systemic lupus erythematosus	6.72e-06	4.97e-05	CbGpPWpGaD
Gefitinib—EGFR—Disease—CD80—systemic lupus erythematosus	6.71e-06	4.96e-05	CbGpPWpGaD
Gefitinib—ALB—Hemostasis—NOS3—systemic lupus erythematosus	6.62e-06	4.89e-05	CbGpPWpGaD
Gefitinib—CSNK1E—Signaling Pathways—VEGFA—systemic lupus erythematosus	6.62e-06	4.89e-05	CbGpPWpGaD
Gefitinib—ERBB3—Disease—TGFB1—systemic lupus erythematosus	6.61e-06	4.88e-05	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—CCL2—systemic lupus erythematosus	6.54e-06	4.83e-05	CbGpPWpGaD
Gefitinib—CSNK1E—Disease—IL6—systemic lupus erythematosus	6.53e-06	4.83e-05	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—systemic lupus erythematosus	6.29e-06	4.65e-05	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—CDKN1B—systemic lupus erythematosus	6.29e-06	4.65e-05	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—IL2—systemic lupus erythematosus	6.15e-06	4.55e-05	CbGpPWpGaD
Gefitinib—EGFR—Immune System—TYK2—systemic lupus erythematosus	6.14e-06	4.54e-05	CbGpPWpGaD
Gefitinib—CSNK1E—Signaling Pathways—TGFB1—systemic lupus erythematosus	6.07e-06	4.49e-05	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—CDKN1B—systemic lupus erythematosus	6.06e-06	4.48e-05	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—systemic lupus erythematosus	6.05e-06	4.47e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—JAK1—systemic lupus erythematosus	6.03e-06	4.46e-05	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—TYK2—systemic lupus erythematosus	5.94e-06	4.39e-05	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—IL2—systemic lupus erythematosus	5.93e-06	4.38e-05	CbGpPWpGaD
Gefitinib—MKNK1—Signaling Pathways—IL6—systemic lupus erythematosus	5.88e-06	4.35e-05	CbGpPWpGaD
Gefitinib—EGFR—Developmental Biology—IL6—systemic lupus erythematosus	5.84e-06	4.31e-05	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—NOS3—systemic lupus erythematosus	5.83e-06	4.31e-05	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—MMP9—systemic lupus erythematosus	5.82e-06	4.3e-05	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—CDKN1A—systemic lupus erythematosus	5.8e-06	4.29e-05	CbGpPWpGaD
Gefitinib—EGFR—Immune System—IFNG—systemic lupus erythematosus	5.75e-06	4.25e-05	CbGpPWpGaD
Gefitinib—CYP3A5—Metabolism—RXRA—systemic lupus erythematosus	5.74e-06	4.24e-05	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—systemic lupus erythematosus	5.74e-06	4.24e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—CCR5—systemic lupus erythematosus	5.72e-06	4.22e-05	CbGpPWpGaD
Gefitinib—EGFR—Disease—TYK2—systemic lupus erythematosus	5.67e-06	4.19e-05	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism of lipids and lipoproteins—ALB—systemic lupus erythematosus	5.66e-06	4.18e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—IL2RA—systemic lupus erythematosus	5.63e-06	4.16e-05	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—MMP9—systemic lupus erythematosus	5.61e-06	4.15e-05	CbGpPWpGaD
Gefitinib—ALB—Hemostasis—IL2—systemic lupus erythematosus	5.61e-06	4.15e-05	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—CDKN1A—systemic lupus erythematosus	5.59e-06	4.13e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling by GPCR—IL2—systemic lupus erythematosus	5.59e-06	4.13e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—C3—systemic lupus erythematosus	5.59e-06	4.13e-05	CbGpPWpGaD
Gefitinib—EGFR—Disease—NOS3—systemic lupus erythematosus	5.56e-06	4.11e-05	CbGpPWpGaD
Gefitinib—EGFR—Immune System—CD4—systemic lupus erythematosus	5.55e-06	4.1e-05	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—EP300—systemic lupus erythematosus	5.52e-06	4.08e-05	CbGpPWpGaD
Gefitinib—ALB—Metabolism of lipids and lipoproteins—PTGS2—systemic lupus erythematosus	5.51e-06	4.07e-05	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism—RXRA—systemic lupus erythematosus	5.42e-06	4.01e-05	CbGpPWpGaD
Gefitinib—ERBB3—Immune System—IL6—systemic lupus erythematosus	5.39e-06	3.99e-05	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—EP300—systemic lupus erythematosus	5.32e-06	3.93e-05	CbGpPWpGaD
Gefitinib—ABCB1—Transmembrane transport of small molecules—ALB—systemic lupus erythematosus	5.25e-06	3.88e-05	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—VEGFA—systemic lupus erythematosus	5.23e-06	3.87e-05	CbGpPWpGaD
Gefitinib—EGFR—Immune System—CDKN1B—systemic lupus erythematosus	5.22e-06	3.86e-05	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism of lipids and lipoproteins—ALB—systemic lupus erythematosus	5.16e-06	3.81e-05	CbGpPWpGaD
Gefitinib—EGFR—Innate Immune System—IL6—systemic lupus erythematosus	5.15e-06	3.81e-05	CbGpPWpGaD
Gefitinib—EGFR—Disease—CD4—systemic lupus erythematosus	5.13e-06	3.79e-05	CbGpPWpGaD
Gefitinib—EGFR—Immune System—IL2—systemic lupus erythematosus	5.11e-06	3.77e-05	CbGpPWpGaD
Gefitinib—EGFR—Disease—PTGS2—systemic lupus erythematosus	5.09e-06	3.76e-05	CbGpPWpGaD
Gefitinib—ABCG2—Metabolism—PPARG—systemic lupus erythematosus	5.06e-06	3.74e-05	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—CDKN1B—systemic lupus erythematosus	5.05e-06	3.73e-05	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—VEGFA—systemic lupus erythematosus	5.04e-06	3.73e-05	CbGpPWpGaD
Gefitinib—ALB—Hemostasis—EP300—systemic lupus erythematosus	5.04e-06	3.72e-05	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	5.03e-06	3.72e-05	CbGpPWpGaD
Gefitinib—ERBB3—Disease—IL6—systemic lupus erythematosus	4.98e-06	3.68e-05	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—systemic lupus erythematosus	4.95e-06	3.66e-05	CbGpPWpGaD
Gefitinib—ALB—Metabolism—RXRA—systemic lupus erythematosus	4.94e-06	3.65e-05	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—IL2—systemic lupus erythematosus	4.94e-06	3.65e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—F2—systemic lupus erythematosus	4.9e-06	3.62e-05	CbGpPWpGaD
Gefitinib—EGFR—Disease—CDKN1B—systemic lupus erythematosus	4.82e-06	3.56e-05	CbGpPWpGaD
Gefitinib—EGFR—Immune System—CDKN1A—systemic lupus erythematosus	4.82e-06	3.56e-05	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—TGFB1—systemic lupus erythematosus	4.8e-06	3.55e-05	CbGpPWpGaD
Gefitinib—ALB—Hemostasis—VEGFA—systemic lupus erythematosus	4.77e-06	3.52e-05	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—NAT2—systemic lupus erythematosus	4.76e-06	3.52e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—CD80—systemic lupus erythematosus	4.7e-06	3.47e-05	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—MMP9—systemic lupus erythematosus	4.67e-06	3.45e-05	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—CDKN1A—systemic lupus erythematosus	4.66e-06	3.44e-05	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—TGFB1—systemic lupus erythematosus	4.63e-06	3.42e-05	CbGpPWpGaD
Gefitinib—ALB—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	4.58e-06	3.39e-05	CbGpPWpGaD
Gefitinib—EGFR—Immune System—EP300—systemic lupus erythematosus	4.58e-06	3.39e-05	CbGpPWpGaD
Gefitinib—CSNK1E—Signaling Pathways—IL6—systemic lupus erythematosus	4.58e-06	3.38e-05	CbGpPWpGaD
Gefitinib—ABCG2—Metabolism—ALB—systemic lupus erythematosus	4.55e-06	3.36e-05	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—systemic lupus erythematosus	4.51e-06	3.33e-05	CbGpPWpGaD
Gefitinib—IRAK1—Immune System—IL6—systemic lupus erythematosus	4.49e-06	3.32e-05	CbGpPWpGaD
Gefitinib—EGFR—Disease—CDKN1A—systemic lupus erythematosus	4.45e-06	3.29e-05	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—RXRA—systemic lupus erythematosus	4.44e-06	3.28e-05	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—EP300—systemic lupus erythematosus	4.43e-06	3.28e-05	CbGpPWpGaD
Gefitinib—ALB—Hemostasis—TGFB1—systemic lupus erythematosus	4.38e-06	3.23e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—CCL2—systemic lupus erythematosus	4.37e-06	3.23e-05	CbGpPWpGaD
Gefitinib—ABCG2—Metabolism—NOS3—systemic lupus erythematosus	4.35e-06	3.21e-05	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—RXRA—systemic lupus erythematosus	4.33e-06	3.2e-05	CbGpPWpGaD
Gefitinib—EGFR—Disease—EP300—systemic lupus erythematosus	4.23e-06	3.13e-05	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—VEGFA—systemic lupus erythematosus	4.2e-06	3.1e-05	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	4.12e-06	3.04e-05	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—RXRA—systemic lupus erythematosus	4.08e-06	3.02e-05	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—RXRA—systemic lupus erythematosus	4.05e-06	2.99e-05	CbGpPWpGaD
Gefitinib—ABCG2—Metabolism—PTGS2—systemic lupus erythematosus	3.98e-06	2.94e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—TYK2—systemic lupus erythematosus	3.97e-06	2.93e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—NOS3—systemic lupus erythematosus	3.9e-06	2.88e-05	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—TGFB1—systemic lupus erythematosus	3.85e-06	2.85e-05	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	3.75e-06	2.77e-05	CbGpPWpGaD
Gefitinib—EGFR—Disease—TGFB1—systemic lupus erythematosus	3.68e-06	2.72e-05	CbGpPWpGaD
Gefitinib—CYP3A5—Metabolism—PPARG—systemic lupus erythematosus	3.62e-06	2.68e-05	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—IL6—systemic lupus erythematosus	3.62e-06	2.67e-05	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—IL6—systemic lupus erythematosus	3.49e-06	2.58e-05	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism—PPARG—systemic lupus erythematosus	3.42e-06	2.53e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—CDKN1B—systemic lupus erythematosus	3.37e-06	2.49e-05	CbGpPWpGaD
Gefitinib—ABCG2—Metabolism—EP300—systemic lupus erythematosus	3.31e-06	2.45e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—IL2—systemic lupus erythematosus	3.3e-06	2.44e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling by GPCR—IL6—systemic lupus erythematosus	3.29e-06	2.43e-05	CbGpPWpGaD
Gefitinib—CYP3A5—Metabolism—ALB—systemic lupus erythematosus	3.26e-06	2.41e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—MMP9—systemic lupus erythematosus	3.13e-06	2.31e-05	CbGpPWpGaD
Gefitinib—ALB—Metabolism—PPARG—systemic lupus erythematosus	3.12e-06	2.31e-05	CbGpPWpGaD
Gefitinib—CYP3A5—Metabolism—NOS3—systemic lupus erythematosus	3.12e-06	2.3e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—CDKN1A—systemic lupus erythematosus	3.11e-06	2.3e-05	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism—ALB—systemic lupus erythematosus	3.08e-06	2.27e-05	CbGpPWpGaD
Gefitinib—EGFR—Immune System—IL6—systemic lupus erythematosus	3e-06	2.22e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—EP300—systemic lupus erythematosus	2.96e-06	2.19e-05	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism—NOS3—systemic lupus erythematosus	2.94e-06	2.18e-05	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—IL6—systemic lupus erythematosus	2.9e-06	2.15e-05	CbGpPWpGaD
Gefitinib—CYP3A5—Metabolism—PTGS2—systemic lupus erythematosus	2.85e-06	2.11e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—VEGFA—systemic lupus erythematosus	2.81e-06	2.07e-05	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—PPARG—systemic lupus erythematosus	2.8e-06	2.07e-05	CbGpPWpGaD
Gefitinib—EGFR—Disease—IL6—systemic lupus erythematosus	2.77e-06	2.05e-05	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—PPARG—systemic lupus erythematosus	2.73e-06	2.02e-05	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism—PTGS2—systemic lupus erythematosus	2.69e-06	1.99e-05	CbGpPWpGaD
Gefitinib—ALB—Metabolism—NOS3—systemic lupus erythematosus	2.68e-06	1.98e-05	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—RXRA—systemic lupus erythematosus	2.67e-06	1.97e-05	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—PPARG—systemic lupus erythematosus	2.58e-06	1.9e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—TGFB1—systemic lupus erythematosus	2.58e-06	1.9e-05	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—PPARG—systemic lupus erythematosus	2.55e-06	1.89e-05	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—ALB—systemic lupus erythematosus	2.52e-06	1.86e-05	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—ALB—systemic lupus erythematosus	2.46e-06	1.82e-05	CbGpPWpGaD
Gefitinib—ALB—Metabolism—PTGS2—systemic lupus erythematosus	2.45e-06	1.81e-05	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—NOS3—systemic lupus erythematosus	2.41e-06	1.78e-05	CbGpPWpGaD
Gefitinib—CYP3A5—Metabolism—EP300—systemic lupus erythematosus	2.37e-06	1.75e-05	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—NOS3—systemic lupus erythematosus	2.35e-06	1.74e-05	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—ALB—systemic lupus erythematosus	2.32e-06	1.71e-05	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—ALB—systemic lupus erythematosus	2.3e-06	1.7e-05	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism—EP300—systemic lupus erythematosus	2.24e-06	1.66e-05	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—NOS3—systemic lupus erythematosus	2.22e-06	1.64e-05	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—PTGS2—systemic lupus erythematosus	2.2e-06	1.63e-05	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—NOS3—systemic lupus erythematosus	2.2e-06	1.62e-05	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—PTGS2—systemic lupus erythematosus	2.15e-06	1.59e-05	CbGpPWpGaD
Gefitinib—ALB—Metabolism—EP300—systemic lupus erythematosus	2.04e-06	1.51e-05	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—PTGS2—systemic lupus erythematosus	2.03e-06	1.5e-05	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—PTGS2—systemic lupus erythematosus	2.01e-06	1.48e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—IL6—systemic lupus erythematosus	1.94e-06	1.43e-05	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—EP300—systemic lupus erythematosus	1.83e-06	1.35e-05	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—EP300—systemic lupus erythematosus	1.79e-06	1.32e-05	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—EP300—systemic lupus erythematosus	1.69e-06	1.25e-05	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—PPARG—systemic lupus erythematosus	1.68e-06	1.24e-05	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—EP300—systemic lupus erythematosus	1.67e-06	1.23e-05	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—ALB—systemic lupus erythematosus	1.51e-06	1.12e-05	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—NOS3—systemic lupus erythematosus	1.45e-06	1.07e-05	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—PTGS2—systemic lupus erythematosus	1.33e-06	9.79e-06	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—EP300—systemic lupus erythematosus	1.1e-06	8.14e-06	CbGpPWpGaD
